Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Prednicarbate

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    7 result(s) found for: Prednicarbate. Displaying page 1 of 1.
    EudraCT Number: 2009-009948-23 Sponsor Protocol Number: H 552 000-0902 Start Date*: Information not available in EudraCT
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an "expanded flo...
    Medical condition: Healthy volunteer trial to investigate whether topical formulations containing octenidine and octenidine plus prednicarbate exert an in vivo antibacterial action on skin surface bacteria multiplied...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-016627-56 Sponsor Protocol Number: H552000-0920 Start Date*: 2009-12-23
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A phase IIa, multi-center, randomized, double-blind study to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding mono-substances...
    Medical condition: 96 male or female patients with candida infections in intertriginous areas at the trunk will be randomized
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-003362-26 Sponsor Protocol Number: H552000-0809 Start Date*: Information not available in EudraCT
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an"expanded flor...
    Medical condition: Healthy volunteer trial to investigate whether topical formulations containing Octenidine and Octenidine plus Prednicarbate exert an in vivo antibacterial action on skin surface bacteria multiplied...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-016626-14 Sponsor Protocol Number: H552000-0919 Start Date*: Information not available in EudraCT
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus correspond...
    Medical condition: 120 male or female patients with symptomatic moderate to severe tinea pedis will be randomized
    Disease: Version SOC Term Classification Code Term Level
    12.0 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-005181-57 Sponsor Protocol Number: GWT12395-2017 Start Date*: 2018-05-07
    Sponsor Name:GWT-TUD GmbH
    Full Title: A randomized, placebo-controlled, double-blind study to scrutinize the efficacy of Secukinumab in patients with moderate to severe atopic dermatitis
    Medical condition: Moderate to serve atopic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10003639 Atopic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-012028-98 Sponsor Protocol Number: 071-007 Start Date*: Information not available in EudraCT
    Sponsor Name:GALENpharma GmbH
    Full Title: A placebo-controlled, multicentre, double-blinded, intra-individual comparison to gain evidence of the safety, tolerability and efficacy of Prednicarbat cream and ointment in patients with active a...
    Medical condition: active atopic dermatitis (according to IGA score 1 - 4)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003639 Atopic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-011931-11 Sponsor Protocol Number: H 552 000 - 0911 Start Date*: Information not available in EudraCT
    Sponsor Name:Almirall Hermal GmbH
    Full Title: Explorative, double-blind, randomized, controlled multi-center phase II study to evaluate the efficacy and safety of topically applied combinational product LAS41003 once daily versus corresponding...
    Medical condition: Patients aged 18 and older suffering from at least one clinically diagnosed superinfected or impetiginised eczema such as e.g. • superinfected or impetiginised atopic eczema • superinfected or impe...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10021773 Infected eczema LLT
    12.0 10014184 Eczema LLT
    12.0 10014188 Eczema allergic LLT
    12.0 10014191 Eczema atopic LLT
    12.0 10014199 Eczema infected LLT
    12.0 10014201 Eczema nummular LLT
    12.0 10051890 Eczema impetiginous LLT
    12.0 10000618 Actinic reticuloid-photosensitive eczema LLT
    12.0 10001712 Allergic eczema LLT
    12.0 10003641 Atopic eczema LLT
    12.0 10010803 Contact eczema LLT
    12.0 10014206 Eczematous dermatitis LLT
    12.0 10021773 Infected eczema LLT
    12.0 10049706 Eczematous dermatitis infected LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 17 14:19:36 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA